Correlation Between Cerevel Therapeutics and Kura Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cerevel Therapeutics and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cerevel Therapeutics and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cerevel Therapeutics Holdings and Kura Oncology, you can compare the effects of market volatilities on Cerevel Therapeutics and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cerevel Therapeutics with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cerevel Therapeutics and Kura Oncology.

Diversification Opportunities for Cerevel Therapeutics and Kura Oncology

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cerevel and Kura is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cerevel Therapeutics Holdings and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Cerevel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cerevel Therapeutics Holdings are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Cerevel Therapeutics i.e., Cerevel Therapeutics and Kura Oncology go up and down completely randomly.

Pair Corralation between Cerevel Therapeutics and Kura Oncology

If you would invest (100.00) in Cerevel Therapeutics Holdings on December 28, 2024 and sell it today you would earn a total of  100.00  from holding Cerevel Therapeutics Holdings or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Cerevel Therapeutics Holdings  vs.  Kura Oncology

 Performance 
       Timeline  
Cerevel Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cerevel Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Cerevel Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Kura Oncology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cerevel Therapeutics and Kura Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cerevel Therapeutics and Kura Oncology

The main advantage of trading using opposite Cerevel Therapeutics and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cerevel Therapeutics position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.
The idea behind Cerevel Therapeutics Holdings and Kura Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency